You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.

Clinical Advances in

HR-Positive, HER2-Negative Early Breast Cancer At High Risk of Recurrence

Read Overview

Supported by an independent educational grant from Lilly

CME Activities

CNE Activities


Steering Committee

Nadia Harbeck, MD, PhD
Nadia Harbeck, MD, PhD

Steering Committee Chair

Head, Breast Center
Chair, Conservative Oncology
Dept. of Obstetrics & Gynecology
University of Munich (LMU)
Munich, Germany

Joyce O'Shaughnessy, MD
Joyce O'Shaughnessy, MD

Steering Committee Chair

Celebrating Women Endowed Chair in Breast Cancer Research
Co-Chair, Breast Cancer Research Program
Baylor University Medical Center
Chair, Breast Cancer Prevention Research
Texas Oncology/US Oncology Network
Dallas, Texas, United States

Giuseppe Curigliano, MD, PhD
Giuseppe Curigliano, MD, PhD

Clinical Director
Division of Early Drug Development for Innovative Therapy
Co-Chair Cancer Experimental Therapeutics Program
Department of Oncology and Hemato-Oncology
University of Milan
European Institute of Oncology
Milan, Italy

Sara A. Hurvitz, MD, FACP
Sara A. Hurvitz, MD, FACP

Professor of Medicine
Director, Breast Cancer Clinical Trials Program, Division of Hematology-Oncology
David Geffen School of Medicine, UCLA
Medical Director, Clinical Research Unit, Jonsson Comprehensive Cancer Center
Santa Monica, California, United States

Stephen R. D. Johnston, MA, FRCP, PhD
Stephen R. D. Johnston, MA, FRCP, PhD

Professor of Breast Cancer Medicine & Head of Medical Oncology
Consultant Medical Oncologist & Head of The Breast Unit
The Royal Marsden NHS Foundation Trust & The Institute of Cancer Research
Chelsea, London, United Kingdom

Sara Tolaney, MD, MPH
Sara Tolaney, MD, MPH

Associate Director, Susan F. Smith Center for Women's Cancers
Director, Clinical Trials, Breast Oncology
Director, Breast Immunotherapy Clinical Research
Senior Physician
Associate Professor of Medicine, Harvard Medical School
Dana Farber Cancer Institute
Boston, Massachusetts